BVI Aqueo Premium TM
Natural health product licensed in Canada
- Licence holder
- Beaver-Visitec International Inc.
- NPN or DIN-HM
- 80027897
- Status
- Active licence
- Licence date
- 1 November 2011
- Revision date
- 15 December 2021
- Form
- Solution
- Route of administration
- Ophthalmique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Chlorure de sodium Source : Chlorure de sodium | 7.14 mg/ml |
| Dibasic sodium phosphate | 0.416 mg/ml |
| Chlorure de potassium Source : Chlorure de potassium | 0.38 mg/ml |
| L-gamma-glutamyl-L-cysteinyl-glycine disulfide | 0.184 mg/ml |
Non-medicinal ingredients
acide hydrochlorique, Eau pour injection
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Indicated for all intraocular surgical procedures, including those requiring a relatively long intraocular perfusion time (e.g. pars plana vitrectomy, phacoemulsification, extracapsular cataract extraction/lens aspiration, reconstruction of the anterior segment, etc). The solution provides effective irrigation to reduce corneal swelling and maintain the integrity of the corneal endothelium during intraocular perfusion. For professional use only.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80027897
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging